Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine

L G Sultatos et al. Clin Pharmacokinet. 1980 May-Jun.

. 1980 May-Jun;5(3):263-73.

doi: 10.2165/00003088-198005030-00005.

No abstract available

Cited by

An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.
Edeki T, Johnston A, Turner P. Edeki T, et al. Eur J Clin Pharmacol. 1990;39(4):405-7. doi: 10.1007/BF00315420. Eur J Clin Pharmacol. 1990. PMID: 2076727
Assessment of methods to identify sources of interindividual pharmacokinetic variations.
Vesell ES, Penno MB. Vesell ES, et al. Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002. Clin Pharmacokinet. 1983. PMID: 6194927 Review.
Drug interactions with cimetidine.
Somogyi A, Gugler R. Somogyi A, et al. Clin Pharmacokinet. 1982 Jan-Feb;7(1):23-41. doi: 10.2165/00003088-198207010-00002. Clin Pharmacokinet. 1982. PMID: 7042171 Review. No abstract available.
Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
Neuvonen PJ, Tokola RA, Kaste M. Neuvonen PJ, et al. Eur J Clin Pharmacol. 1981;21(3):215-20. doi: 10.1007/BF00627923. Eur J Clin Pharmacol. 1981. PMID: 7318881
Prolongation of antipyrine half-life after correction of severe anaemia due to hookworm infestation.
Desai NK, Karbhari K, Paul T, Kshirsagar NA, Sheth UK. Desai NK, et al. Br J Clin Pharmacol. 1982 May;13(5):745-7. doi: 10.1111/j.1365-2125.1982.tb01451.x. Br J Clin Pharmacol. 1982. PMID: 7082546 Free PMC article. No abstract available.